Log In
Print this Print this

Entyvio, vedolizumab (MLN0002)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionHumanized mAb against integrin alpha(4)beta(7)
Molecular Target Integrin alpha(4)beta(7)
Mechanism of ActionBinds integrin alpha(4)beta(7); Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today